| CASMASCI | progen | BOC | 進(jìn)口現(xiàn)貨產(chǎn)品 | 胎牛血清 | 細(xì)胞培養(yǎng) | 提取試劑 | 轉(zhuǎn)染試劑 | 常規(guī)生化試劑 | ELISA試劑盒 | 抗體 | 細(xì)胞因子 | sigma aldrich(西格瑪) | Invitrogen(英駿) | Millipore | Abcam | CST | Roche | peprotech | prospec | pierce | BD Pharmingen | BD Biocoat | R&D | BioVision | Vector | Enzo life | eBioscience | ABR | Amresco | Cayman Chemical | 脂蛋白 | Merck | Qiagen(凱杰) | Santa cruz(三塔抗體) |
產(chǎn)品名稱:Oxaliplatin
產(chǎn)品貨號(hào):LKT O9201
產(chǎn)品規(guī)格:5 g
Description
A novel platinum analogue which has wide spectrum anti-cancer activity. It is found to be more active against human melanoma cell lines, and has better biochemical, pharmacological and cytotoxic properties than cisplatin and carboplatin.
Specifications
Cas No. 61825-94-3
Product ID O9201
Product Name Oxaliplatin
Chemical Name (SP-4-2)-[(1R,2R)-1.2-Cyclohexanediamine-?N,?N']- [ethanedioato(2-)-?O1,?O2]platinum
Synonym Oxalatoplatin; Oxalatoplatinum
Formula Wt. 397.29
Melting Point 260oC
Purity ≥98%
Solubility Soluble in water (10 mM, 4 mg/mL), DMSO (50 mM or 20 mg /mL).
Store Temp -20oC
Ship Temp Ambient
References Cassidy J. Int. J. Clin. Pract. 54:399-402, (2000). Mohammed MQ, Retsas S. Anticancer Drugs. 11:859-63, (2000).